Prioritizing pharmacogenomics implementation initiatives - survey of healthcare professionals (vol 19, pg 15, 2021)

Aim: Characterize current perceptions, practices, preferences and barriers to integrating pharmacogenomics into patient care at an institution with an established pharmacogenomics clinic. Materials & methods: A 16-item anonymous survey was sent to healthcare professionals practicing at Tampa General Hospital and the University of South Florida Health. Results: Survey participants consisted of nine advanced practice providers, 41 pharmacists and 64 physicians. Majority of survey participants did not feel confident in their ability to interpret and apply pharmacogenomic results. In the past 12 months, 27% of physicians reported ordering a pharmacogenomic test. The greatest reported barrier to integrating pharmacogenomics was the absence of established guidelines or protocols. Conclusion: Most clinicians believed pharmacogenomics would be useful in their clinical practice but do not feel prepared to interpret pharmacogenomic results. Lay abstract Pharmacogenomics is a field of personalized medicine where genetic information may be used to guide treatment decisions. Many advanced practice providers, pharmacists, and physicians are not as familiar with interpreting pharmacogenomic results to make medication changes. This survey was designed and administered to clinicians at Tampa General Hospital and the University of South Florida Health to characterize perceptions, practices, preferences and barriers to integrating pharmacogenomics into patient care. Survey results revealed that most clinicians believed pharmacogenomics would be useful in their clinical practice but do not feel prepared to interpret pharmacogenomic results.